• Latest Posts

Ultra-long protein fibrils could help with early Alzheimer’s diagnosis

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline 

6 new vaccines being developed for difficult-to-treat diseases

Alzamend pushing ahead with Alzheimer’s vaccine trial

€260M fund addresses dementia investment shortfall

5 advancements in Down syndrome research over the past year


Could changing mRNA provide a new target for Alzheimer’s disease?

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases

Silo Pharma looks into the 2023 psychedelics crystal ball